De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Dallah Healthcare Inkomsten in het verleden
Verleden criteriumcontroles 5/6
Dallah Healthcare is de winst gegroeid met een gemiddeld jaarlijks percentage van 25.5%, terwijl de Healthcare industrie de winst jaarlijks groeide met 18.7%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 21.5% per jaar. Het rendement op eigen vermogen van Dallah Healthcare is 12.9%, en het heeft een nettomarge van 14.3%.
Belangrijke informatie
25.5%
Groei van de winst
23.1%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 12.3% |
| Inkomstengroei | 21.5% |
| Rendement op eigen vermogen | 12.9% |
| Nettomarge | 14.3% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Do Dallah Healthcare's (TADAWUL:4004) Earnings Warrant Your Attention?
Sep 19
Dallah Healthcare Company (TADAWUL:4004) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 14The Price Is Right For Dallah Healthcare Company (TADAWUL:4004)
Jul 18Investors Will Want Dallah Healthcare's (TADAWUL:4004) Growth In ROCE To Persist
May 30We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Apr 16What You Can Learn From Dallah Healthcare Company's (TADAWUL:4004) P/E
Mar 18Returns On Capital At Dallah Healthcare (TADAWUL:4004) Have Hit The Brakes
Feb 25Dallah Healthcare (TADAWUL:4004) Has More To Do To Multiply In Value Going Forward
Oct 30Dallah Healthcare (TADAWUL:4004) Is Reinvesting At Lower Rates Of Return
Jul 26Returns On Capital Signal Tricky Times Ahead For Dallah Healthcare (TADAWUL:4004)
Apr 17Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Feb 06Dallah Healthcare (TADAWUL:4004) Will Want To Turn Around Its Return Trends
Dec 05We Ran A Stock Scan For Earnings Growth And Dallah Healthcare (TADAWUL:4004) Passed With Ease
Nov 01Calculating The Intrinsic Value Of Dallah Healthcare Company (TADAWUL:4004)
Aug 28Dallah Healthcare (TADAWUL:4004) Has Some Way To Go To Become A Multi-Bagger
Aug 12Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Jul 28Industry Analysts Just Upgraded Their Dallah Healthcare Company (TADAWUL:4004) Revenue Forecasts By 10%
May 26Calculating The Fair Value Of Dallah Healthcare Company (TADAWUL:4004)
May 20Here's Why We Think Dallah Healthcare (TADAWUL:4004) Is Well Worth Watching
Apr 16Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Feb 03Is Now The Time To Put Dallah Healthcare (TADAWUL:4004) On Your Watchlist?
Jan 10Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Oct 19Dallah Healthcare (TADAWUL:4004) Might Be Having Difficulty Using Its Capital Effectively
Jul 09Forecast: Analysts Think Dallah Healthcare Company's (TADAWUL:4004) Business Prospects Have Improved Drastically
Jun 16Broker Revenue Forecasts For Dallah Healthcare Company (TADAWUL:4004) Are Surging Higher
May 02What Kind Of Shareholders Hold The Majority In Dallah Healthcare Company's (TADAWUL:4004) Shares?
Mar 17Has Dallah Healthcare (TADAWUL:4004) Got What It Takes To Become A Multi-Bagger?
Mar 02Dallah Healthcare (TADAWUL:4004) Shareholders Booked A 45% Gain In The Last Year
Feb 15Should You Buy Dallah Healthcare Company (TADAWUL:4004) For Its Dividend?
Feb 01Are Dallah Healthcare's (TADAWUL:4004) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 05
Dallah Healthcare Company's (TADAWUL:4004) Intrinsic Value Is Potentially 26% Below Its Share Price
Dec 22Will Dallah Healthcare (TADAWUL:4004) Multiply In Value Going Forward?
Nov 20Opbrengsten en kosten
Hoe Dallah Healthcare geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 3,105 | 444 | 580 | 0 |
| 31 Mar 24 | 3,010 | 385 | 565 | 0 |
| 31 Dec 23 | 2,943 | 360 | 549 | 0 |
| 30 Sep 23 | 2,831 | 325 | 537 | 0 |
| 30 Jun 23 | 2,682 | 270 | 487 | 0 |
| 31 Mar 23 | 2,595 | 286 | 456 | 0 |
| 31 Dec 22 | 2,488 | 274 | 443 | 0 |
| 30 Sep 22 | 2,370 | 305 | 464 | 0 |
| 30 Jun 22 | 2,313 | 311 | 450 | 0 |
| 31 Mar 22 | 2,220 | 289 | 434 | 0 |
| 31 Dec 21 | 2,105 | 259 | 416 | 0 |
| 30 Sep 21 | 1,935 | 202 | 402 | 0 |
| 30 Jun 21 | 1,742 | 206 | 371 | 0 |
| 31 Mar 21 | 1,498 | 165 | 331 | 0 |
| 31 Dec 20 | 1,318 | 132 | 307 | 0 |
| 30 Sep 20 | 1,257 | 150 | 277 | 0 |
| 30 Jun 20 | 1,207 | 123 | 272 | 0 |
| 31 Mar 20 | 1,246 | 131 | 287 | 0 |
| 31 Dec 19 | 1,252 | 147 | 286 | 0 |
| 30 Sep 19 | 1,227 | 110 | 304 | 0 |
| 30 Jun 19 | 1,206 | 115 | 295 | 0 |
| 31 Mar 19 | 1,193 | 119 | 293 | 0 |
| 31 Dec 18 | 1,181 | 142 | 286 | 0 |
| 30 Sep 18 | 1,189 | 172 | 281 | 0 |
| 30 Jun 18 | 1,203 | 217 | 274 | 0 |
| 31 Mar 18 | 1,218 | 268 | 260 | 0 |
| 31 Dec 17 | 1,212 | 295 | 246 | 0 |
| 30 Sep 17 | 1,202 | 284 | 254 | 0 |
| 30 Jun 17 | 1,180 | 268 | 265 | 0 |
| 31 Mar 17 | 1,181 | 252 | 275 | 0 |
| 31 Dec 16 | 1,163 | 225 | 288 | 0 |
| 30 Sep 16 | 1,122 | 228 | 264 | 0 |
| 30 Jun 16 | 1,073 | 194 | 255 | 0 |
| 31 Mar 16 | 1,030 | 175 | 249 | 0 |
| 31 Dec 15 | 985 | 165 | 231 | 0 |
| 30 Sep 15 | 948 | 161 | 219 | 0 |
| 30 Jun 15 | 917 | 156 | 211 | 0 |
| 31 Mar 15 | 892 | 154 | 206 | 0 |
| 31 Dec 14 | 859 | 147 | 201 | 0 |
| 30 Sep 14 | 831 | 149 | 203 | 0 |
| 30 Jun 14 | 805 | 149 | 194 | 0 |
| 31 Mar 14 | 773 | 138 | 184 | 0 |
| 31 Dec 13 | 750 | 137 | 182 | 0 |
Kwaliteitswinsten: 4004 heeft hoge kwaliteitsinkomsten.
Groeiende winstmarge: De huidige netto winstmarges (14.3%) 4004 } zijn hoger dan vorig jaar (10.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: De winst van 4004 is de afgelopen 5 jaar aanzienlijk gegroeid met 25.5% per jaar.
Versnelling van de groei: De winstgroei van 4004 over het afgelopen jaar ( 64.3% ) overtreft het 5-jarig gemiddelde ( 25.5% per jaar).
Winst versus industrie: De winstgroei 4004 over het afgelopen jaar ( 64.3% ) overtrof de Healthcare -sector 36.5%.
Rendement op eigen vermogen
Hoge ROE: Het Rendement op eigen vermogen ( 12.9% ) van 4004 wordt als laag beschouwd.